Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06057480 · ClinicalTrials.gov registry record · NA
APM in the Evoke SCS System to Program Patients With Chronic Pain of the Trunk and/or Limbs
A NA study, sponsored by Saluda Medical Pty.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06057480: Completed NA study, sponsored by Saluda Medical Pty.
NCT06057480 is a NA study that has completed, run by Saluda Medical Pty. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06057480, a NA study, has completed, sponsored by Saluda Medical Pty.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Study to evaluate the use of the Assisted Programming Module (APM) in the Evoke Spinal Cord Stimulation (SCS) System to program patients with chronic pain of the trunk and/or limbs.
Primary Outcome
Change in Evoked Compound Action Potentials (ECAPs) measured in µV by the Evoke SCS System
Interventions
- DEVICE APM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-09-26 |
| Est. Completion | 2024-12-19 |
| Phase | NA |
What the finished NCT06057480 record still lists
NCT06057480 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which APM is the first listed.
NCT06057480 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06057480 about?
NCT06057480 is a clinical study titled "APM in the Evoke SCS System to Program Patients With Chronic Pain of the Trunk and/or Limbs". Study to evaluate the use of the Assisted Programming Module (APM) in the Evoke Spinal Cord Stimulation (SCS) System to program patients with chronic pain of the trunk and/or limbs.
What is the current status of trial NCT06057480?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-09-26. Estimated completion is 2024-12-19.
What interventions are being tested in trial NCT06057480?
The interventions under investigation include: APM (DEVICE).
Who is sponsoring clinical trial NCT06057480?
This trial is sponsored by Saluda Medical Pty, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06057480's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI